3004 90 92 56

Code

3004 90 92 56

Type

10-digit tariff line

Duty rate

Free (set at subheading 30049092)

Unit

kg

Classification rulings (U.S. Customs, CROSS)

• N339838 · 2024-05-30 — The tariff classification of Famotidine Injection in dosage form, from India

  Famotidine Injection, imported in dosages of 20 mg/2 mL (10 mg/mL) vials, is a histamine H2 receptor antagonist. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Famotidine Injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in patients who are unable to take oral medication for the following conditions: short term treatment of active duodenal ulcer, maintenance therapy for duodenal ulcer patients at…

• H312361 · 2023-08-21 — Revocation of NY N276739 and HQ 957022; Classification of sodium bicarbonate cartridges/bags

  This is in reference to New York Ruling Letter (NY) N276739, issued to you by U.S. Customs and Border Protection (CBP) on July 12, 2016, concerning classification of a “Bibag” from France, under the Harmonized Tariff Schedule of the United States (HTSUS). We have reviewed that decision, and determined that it is incorrect, and for the reasons set forth below, are revoking your ruling. We have also reviewed Headquarters Ruling (HQ) 957022, dated January 24, 1995, and for similar reasons set forth below, are revoking that ruling. Pursuant to section 625(c)(1), Tariff Act of 1930 (19 U.S.C.…

• H304287 · 2019-10-29 — Tariff classification of Sevoflurane packaged in 250 ml bottles

  for a binding ruling regarding the tariff classification of Sevoflurane under the Harmonized Tariff Schedule of the United States (HTSUS). FACTS: Sevoflurane is an inhalation anesthesia. It is manufactured from Hexafluroisopropyl Methyl Ether sourced from India and/or China. It is packaged in bottles of 250 ml which are sold to pharmaceutical distributors in boxes of six. You state that Sevoflurane from a single 250 ml bottle may be used for one or more patients by the anesthesiologist, based on the particular patient. The sample label on the 250 ml bottle that you provided and package insert…

• 3004 90 92 36 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Other
• 3004 90 92 37 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing dexmedetomidine, etomidate,…
• 3004 90 92 38 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing midazolam or its salts
• 3004 90 92 39 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing phenytoin or its salts
• 3004 90 92 40 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing propofol or its salts
• 3004 90 92 41 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing levetiracetam, phenytoin or their…
• 3004 90 92 42 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing etomidate or its salts
• 3004 90 92 43 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Other
• 3004 90 92 44 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 45 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 46 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Other
• 3004 90 92 47 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing rocuronium or its salts
• 3004 90 92 48 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing succinylcholine or its salts
• 3004 90 92 49 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Other
• 3004 90 92 50 — Other: — Dermatological agents and local anesthetics: — Containing lidocaine or its salts
• 3004 90 92 51 — Other: — Dermatological agents and local anesthetics: — Other
• 3004 90 92 52 — Other: — Medicaments primarily affecting the digestive system: — Laxatives
• 3004 90 92 53 — Other: — Medicaments primarily affecting the digestive system: — Antacids
• 3004 90 92 54 — Other: — Medicaments primarily affecting the digestive system: — Containing famotidine or its salts
• 3004 90 92 55 — Other: — Medicaments primarily affecting the digestive system: — Containing pantoprazole or its salts
• 3004 90 92 57 — Other: — Medicaments primarily affecting the digestive system: — Containing glycopyrrolate or its salts
• 3004 90 92 58 — Other: — Medicaments primarily affecting the digestive system: — Containing loperamide or its salts
• 3004 90 92 60 — Other: — Medicaments primarily affecting the digestive system: — Other
• 3004 90 92 61 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing furosemide and its salts
• 3004 90 92 62 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing hydrochlorothiazide or its salts
• 3004 90 92 63 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Other
• 3004 90 92 64 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing calcium gluconate
• 3004 90 92 65 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing potassium chloride
• 3004 90 92 66 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing sodium bicarbonate, in injection form
• 3004 90 92 67 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Other
• 3004 90 92 68 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Cough and cold preparations
• 3004 90 92 69 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Antihistamines: — Containing diphenhydramine or its salts
• 3004 90 92 70 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Antihistamines: — Other
• 3004 90 92 71 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Containing albuterol sulfate
• 3004 90 92 72 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Containing timolol maleate
• 3004 90 92 73 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Other
• 3004 90 92 74 — Other: — Other: — Containing heparin sodium or its salts
• 3004 90 92 75 — Other: — Other: — Containing zoledronic acid or its salts
• 3004 90 92 76 — Other: — Other: — Other

• 30049 — ТН ВЭД ЕАЭС: прочие:
• 300490 — EU CN/TARIC: Other

Related news

• FMC proposes $200,000 fee on Spanish-flag ships and curbs on Spanish imports
• BIS details zero-tariff drug categories ahead of September 29 tariff

Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.